The Global Cardiac Rhythm Management (CRM) Devices Industry Market Research Report 2018 is a professional and in-depth study on the current state of the Cardiac Rhythm Management (CRM) Devices industry.
Get a full report sample:
Click to request a sample:
This report studies the global Cardiac Rhythm Management (CRM) Devices market status and forecast, categorizes the global Cardiac Rhythm Management (CRM) Devices market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
Cardiac Rhythm Management Device is a medical device which uses electrical impulses, delivered by electrodes contracting the heart muscles, to regulate the beating of the heart.
A cardiac rhythm management device (CRMD) refers to any permanently implanted cardiac pacemaker or any implantable cardioverter-defibrillator (ICD). The term CRMD also refers to any cardiac resynchronization device. The term CRT refers to a CRMD that provides cardiac resynchronization therapy using biventricular pacing techniques.
Increasing instances of heart failure and other cardiac disorders and rising sedentary lifestyle among the population are estimated to boost market growth through 2025.
The classification of Cardiac Rhythm Management Device includes Pacemakers, ICD and CRT. And the proportion of Pacemakers in 2017 is about 49.1%. The ICD in 2017 is about 36.6%.
Cardiac Rhythm Management Device is widely used in Bradycardia, Tachycardia, heart failure and other. Tachycardia and bradycardia are the most common indications for treatment, heart failure, diabetes and obesity can contribute to ongoing rhythm management concerns. And the market share used tachycardia in 2017 is 42.8%. And the market share used bradycardia in 2018 is 39.9%.
North America region is the largest supplier of Cardiac Rhythm Management Device, with a production market share nearly 84.7% in 2017. Europe is the second largest supplier of Cardiac Rhythm Management Device Media, enjoying production market share nearly 12.4% in 2017.
North America is the largest consumption place, with a consumption market share nearly 51.5% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 28.3%, Cardiac Rhythm Management Device market in Asia Pacific region is expected to exhibit the highest growth rate especially in the developing Asian countries like China & India.
Market competition is intense among top 5. Medtronic, St. Jude Medical (Abbott), Boston Scientific, Biotronik, LivaNova (Sorin) are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The global Cardiac Rhythm Management (CRM) Devices market is valued at 10200 million US$ in 2017 and will reach 14500 million US$ by the end of 2025, growing at a CAGR of 4.5% during 2018-2025.
The major manufacturers covered in this report
St. Jude Medical (Abbott)
Lepu (Qinming Medical)
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
We can also provide the customized separate regional or country-level reports, for the following regions:
Rest of Asia-Pacific
Rest of Europe
Central & South America
Rest of South America
Middle East & Africa
Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
The study objectives of this report are:
To analyze and study the global Cardiac Rhythm Management (CRM) Devices sales, value, status (2013-2017) and forecast (2018-2025).
Focuses on the key Cardiac Rhythm Management (CRM) Devices manufacturers, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Cardiac Rhythm Management (CRM) Devices are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Cardiac Rhythm Management (CRM) Devices Manufacturers
Cardiac Rhythm Management (CRM) Devices Distributors/Traders/Wholesalers
Cardiac Rhythm Management (CRM) Devices Subcomponent Manufacturers
With the given market data, QYResearch offers customizations according to the company’s specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Cardiac Rhythm Management (CRM) Devices market, by end-use.
Detailed analysis and profiles of additional market players.
If want more message,please contact us: firstname.lastname@example.org
QY Research, INC.
17890 Castleton, Suite 218,
City of industry, CA – 91748
USA: +1 626 295 2442
Web – www.qyresearch.com